Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_provenance.
- NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_assertion description "[The effect of the EGFR tyrosine kinase inhibitor BIBX1382BS on radiation sensitivity was determined after single- and fractionated-dose irradiation in human cell lines of bronchial carcinoma (A549), breast adeno-carcinoma (MDA-MB-231), pharyngeal squamous-cell carcinoma (FaDu), squamous-cell carcinoma of cervix (HTB-35) as well as normal (HSF-7) and transformed (HH4-DED) human skin fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_provenance.
- NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_assertion evidence source_evidence_literature NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_provenance.
- NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_assertion SIO_000772 15734199 NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_provenance.
- NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_assertion wasDerivedFrom befree-2016 NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_provenance.
- NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_assertion wasGeneratedBy ECO_0000203 NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_provenance.
- befree-2016 importedOn "2016-02-19" NP482621.RA5W5J_l1FDu5ApuxQQ4v3D4Ou1qLvUlkBiCAsoxFOa80130_provenance.